Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Gains from Investment Securities: 2015-2019

Historic Gains from Investment Securities for Wave Life Sciences (WVE) over the last 4 years, with Sep 2019 value amounting to $2.6 million.

  • Wave Life Sciences' Gains from Investment Securities rose 25510.00% to $2.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $7.5 million, marking a year-over-year increase of 1725.87%. This contributed to the annual value of $12.0 million for FY2022, which is 166.92% up from last year.
  • According to the latest figures from Q3 2019, Wave Life Sciences' Gains from Investment Securities is $2.6 million, which was up 9.87% from $2.3 million recorded in Q2 2019.
  • In the past 5 years, Wave Life Sciences' Gains from Investment Securities ranged from a high of $3.2 million in Q2 2016 and a low of -$416,000 during Q4 2017.
  • For the 3-year period, Wave Life Sciences' Gains from Investment Securities averaged around $722,000, with its median value being $14,500 (2017).
  • Per our database at Business Quant, Wave Life Sciences' Gains from Investment Securities tumbled by 183.03% in 2017 and then skyrocketed by 25,510.00% in 2019.
  • Wave Life Sciences' Gains from Investment Securities (Quarterly) stood at $2.7 million in 2015, then crashed by 81.15% to $501,000 in 2016, then plummeted by 183.03% to -$416,000 in 2017, then declined by 9.09% to $10,000 in 2018, then skyrocketed by 25,510.00% to $2.6 million in 2019.
  • Its last three reported values are $2.6 million in Q3 2019, $2.3 million for Q2 2019, and $2.6 million during Q1 2019.